CAH Quote, Financials, Valuation and Earnings

Cencora, Inc. has a net margin of 0.71% compared to Cardinal Health, Inc.'s net margin of -0.4%. Cardinal Health, Inc.'s return on equity of -- beat Cencora, Inc.'s return on equity of 124.72%.

Cardinal Health, Inc. has a consensus price target of $226.93, signalling upside risk potential of 9.69%. On the other hand Cencora, Inc. has an analysts' consensus of $396.80 which suggests that it could grow by 12.58%. Given that Cencora, Inc. has higher upside potential than Cardinal Health, Inc., analysts believe Cencora, Inc. is more attractive than Cardinal Health, Inc..

Cardinal Health, Inc. has a beta of 0.644, which suggesting that the stock is 35.629% less volatile than S&P 500. In comparison Cencora, Inc. has a beta of 0.664, suggesting its less volatile than the S&P 500 by 33.595%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 0.99%. Cencora, Inc. offers a yield of 0.64% to investors and pays a quarterly dividend of $0.60 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. Cencora, Inc. pays out 27.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $64B, which are smaller than Cencora, Inc. quarterly revenues of $83.7B. Cardinal Health, Inc.'s net income of $454M is higher than Cencora, Inc.'s net income of -$333.1M. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 31.23x while Cencora, Inc.'s PE ratio is 44.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.21x versus 0.21x for Cencora, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

CVS Health Corp. has a net margin of 0.71% compared to Cardinal Health, Inc.'s net margin of -3.88%. Cardinal Health, Inc.'s return on equity of -- beat CVS Health Corp.'s return on equity of 0.57%.

Cardinal Health, Inc. has a consensus price target of $226.93, signalling upside risk potential of 9.69%. On the other hand CVS Health Corp. has an analysts' consensus of $94.96 which suggests that it could grow by 14.85%. Given that CVS Health Corp. has higher upside potential than Cardinal Health, Inc., analysts believe CVS Health Corp. is more attractive than Cardinal Health, Inc..

Cardinal Health, Inc. has a beta of 0.644, which suggesting that the stock is 35.629% less volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.486, suggesting its less volatile than the S&P 500 by 51.445%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 0.99%. CVS Health Corp. offers a yield of 3.22% to investors and pays a quarterly dividend of $0.67 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. CVS Health Corp. pays out 72.76% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $64B, which are smaller than CVS Health Corp. quarterly revenues of $102.9B. Cardinal Health, Inc.'s net income of $454M is higher than CVS Health Corp.'s net income of -$4B. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 31.23x while CVS Health Corp.'s PE ratio is 216.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.21x versus 0.27x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

McKesson Corp. has a net margin of 0.71% compared to Cardinal Health, Inc.'s net margin of 1.13%. Cardinal Health, Inc.'s return on equity of -- beat McKesson Corp.'s return on equity of --.

Cardinal Health, Inc. has a consensus price target of $226.93, signalling upside risk potential of 9.69%. On the other hand McKesson Corp. has an analysts' consensus of $942.00 which suggests that it could grow by 15.29%. Given that McKesson Corp. has higher upside potential than Cardinal Health, Inc., analysts believe McKesson Corp. is more attractive than Cardinal Health, Inc..

Cardinal Health, Inc. has a beta of 0.644, which suggesting that the stock is 35.629% less volatile than S&P 500. In comparison McKesson Corp. has a beta of 0.408, suggesting its less volatile than the S&P 500 by 59.158%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 0.99%. McKesson Corp. offers a yield of 0.38% to investors and pays a quarterly dividend of $0.82 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. McKesson Corp. pays out 10.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $64B, which are smaller than McKesson Corp. quarterly revenues of $103.2B. Cardinal Health, Inc.'s net income of $454M is lower than McKesson Corp.'s net income of $1.2B. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 31.23x while McKesson Corp.'s PE ratio is 25.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.21x versus 0.27x for McKesson Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Pineapple, Inc. has a net margin of 0.71% compared to Cardinal Health, Inc.'s net margin of -184.62%. Cardinal Health, Inc.'s return on equity of -- beat Pineapple, Inc.'s return on equity of --.

Cardinal Health, Inc. has a consensus price target of $226.93, signalling upside risk potential of 9.69%. On the other hand Pineapple, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cardinal Health, Inc. has higher upside potential than Pineapple, Inc., analysts believe Cardinal Health, Inc. is more attractive than Pineapple, Inc..

Cardinal Health, Inc. has a beta of 0.644, which suggesting that the stock is 35.629% less volatile than S&P 500. In comparison Pineapple, Inc. has a beta of 41.025, suggesting its more volatile than the S&P 500 by 4002.548%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 0.99%. Pineapple, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. Pineapple, Inc. pays out -- of its earnings as a dividend. Cardinal Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $64B, which are larger than Pineapple, Inc. quarterly revenues of $1.3K. Cardinal Health, Inc.'s net income of $454M is higher than Pineapple, Inc.'s net income of -$2.4K. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 31.23x while Pineapple, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.21x versus 52.83x for Pineapple, Inc.. Usually stocks with elevated PS ratios are considered overvalued.